Public filings / BSX on Yahoo Finance (opens in a new tab)
BSX: insider buying, 13F holders, analyst moves
Boston Scientific Corp - US
A summary of public filings about Boston Scientific Corp - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
7 of our 100 managers hold BSX
Combined reported value $837.3M; 2 sold out since Q1 2026.
Holders among our 100 managers: 3 in Q3 2023, 7 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Farallon Capital | $449.0M | 2.63% | Added |
| Maverick Capital | $253.4M | 2.29% | Added |
| Tudor Investment | $63.1M | 0.26% | Added |
| Deerfield Company | $56.1M | 0.58% | New |
| Perceptive Advisors | $10.7M | 0.17% | New |
| Glenview Capital | $4.8M | 0.10% | New |
| Polen Capital | $203K | 0.00% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.